The cost-effectiveness of a controversial test promoted as a multicancer early detection (MCED) tool from a single blood sample has been scrutinised in an investigation by the BMJ. The investigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback